Lara Ward

546 total citations
14 papers, 263 citations indexed

About

Lara Ward is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Lara Ward has authored 14 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Genetics and 4 papers in Oncology. Recurrent topics in Lara Ward's work include PI3K/AKT/mTOR signaling in cancer (8 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Advanced Breast Cancer Therapies (3 papers). Lara Ward is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (8 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Advanced Breast Cancer Therapies (3 papers). Lara Ward collaborates with scholars based in United Kingdom, France and Sweden. Lara Ward's co-authors include Martina Fitzek, Urs J. Hancox, Kevin Hudson, Sabina Cosulich, Stephen Green, Huihai Wu, Nick Plant, Bernard Barlaam, Christine Lambert‐van der Brempt and Andrzej Kierzek and has published in prestigious journals such as Cancer Research, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Lara Ward

13 papers receiving 254 citations

Peers

Countries citing papers authored by Lara Ward

Since Specialization

Citations

This map shows the geographic impact of Lara Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Ward more than expected).

Fields of papers citing papers by Lara Ward

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Ward. The network helps show where Lara Ward may publish in the future.

Co-authorship network of co-authors of Lara Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Lara Ward. A scholar is included among the top collaborators of Lara Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara Ward. Lara Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Discovery of a novel aminopyrazine series as selective PI3Kα inhibitors 2017 ·Bioorganic & Medicinal Chemistry Letters ·Bernard Barlaam, Sabina Cosulich, Martina Fitzek, (unknown), Stephen Green, Lyndsey Hanson, Craig S. Harris, Urs J. Hancox, Kevin Hudson, Christine Lambert‐van der Brempt, (unknown), (unknown), Gilles Ouvry, Ken Page, Linette Ruston, Lara Ward, Bénédicte Delouvrié	5
2	Discovery of a series of 8-(1-phenylpyrrolidin-2-yl)-6-carboxamide-2-morpholino-4H-chromen-4-one as PI3Kβ/δ inhibitors for the treatment of PTEN-deficient tumours 2017 ·Bioorganic & Medicinal Chemistry Letters ·Bernard Barlaam, Sabina Cosulich, Sébastien L. Degorce, Rebecca Ellston, Martina Fitzek, Stephen Green, Urs J. Hancox, Christine Lambert‐van der Brempt, (unknown), (unknown), Rémy Morgentin, Patrick A. Plé, Lara Ward, Nicolas Warin	3
3	Intermittent High-Dose Scheduling of AZD8835, a Novel Selective Inhibitor of PI3Kα and PI3Kδ, Demonstrates Treatment Strategies for PIK3CA -Dependent Breast Cancers 2016 ·Molecular Cancer Therapeutics ·Kevin Hudson, Urs J. Hancox, Cath Trigwell, Robert McEwen, Urszula M. Polanska, (unknown), Pablo Morentin Gutierrez, Alvaro Avivar‐Valderas, Oona Delpuech, Phillippa Dudley, Lyndsey Hanson, Rebecca Ellston, (unknown), Marie Cumberbatch, Sabina Cosulich, Lara Ward, Francisco Cruzalegui, Stephen Green	36
4	Discovery of a series of 8-(2,3-dihydro-1,4-benzoxazin-4-ylmethyl)-2-morpholino-4-oxo-chromene-6-carboxamides as PI3Kβ/δ inhibitors for the treatment of PTEN-deficient tumours 2016 ·Bioorganic & Medicinal Chemistry Letters ·Bernard Barlaam, Sabina Cosulich, Sébastien L. Degorce, Martina Fitzek, Stephen Green, Urs J. Hancox, Christine Lambert‐van der Brempt, (unknown), (unknown), Rémy Morgentin, (unknown), Patrick A. Plé, (unknown), Lara Ward, Nicolas Warin	6
5	Generation of 2,000 breast cancer metabolic landscapes reveals a poor prognosis group with active serotonin production 2016 ·Scientific Reports ·(unknown), Huihai Wu, Lara Ward, Andrzej Kierzek, Nick Plant	28
6	MUFINS: multi-formalism interaction network simulator 2016 ·npj Systems Biology and Applications ·Huihai Wu, Axel von Kamp, (unknown), Wataru Mori, (unknown), (unknown), (unknown), M. Grabowski, Ahmad A. Mannan, Nicholas Stoy, Graham R. Stewart, Lara Ward, David Lewis, Jacek Sroka, Hiroshi Matsuno, Steffen Klamt, Hans V. Westerhoff, Johnjoe McFadden, Nick Plant, Andrzej Kierzek	17
7	Design of selective PI3Kα inhibitors starting from a promiscuous pan kinase scaffold 2015 ·Bioorganic & Medicinal Chemistry Letters ·Bernard Barlaam, Sabina Cosulich, Martina Fitzek, Stephen Green, Craig S. Harris, Kevin Hudson, Christine Lambert‐van der Brempt, Gilles Ouvry, Ken Page, Linette Ruston, Lara Ward, Bénédicte Delouvrié	7
8	Abstract 2830: Discovery of AZD8835, a potent and selective inhibitor of PI3Kα and PI3Kδ for the treatment of PIK3CA-dependent cancers 2015 ·Cancer Research ·Bernard Barlaam, Sabina Cosulich, Bénédicte Delouvrié, Martina Fitzek, (unknown), Stephen Green, Craig S. Harris, Kevin Hudson, Christine Lambert‐van der Brempt, (unknown), (unknown), Rémy Morgentin, Gilles Ouvry, Ken Page, Georges Pasquet, Linette Ruston, (unknown), (unknown), Lara Ward	0
9	Abstract 2665: High dose intermittent scheduling of AZD8835, a novel potent and selective inhibitor of PI3Kα and PI3Kδ, identifies potential treatment strategies for PIK3CA-dependent cancers 2015 ·Cancer Research ·Kevin Hudson, Urs J. Hancox, Cath Trigwell, Phillippa Dudley, Lyndsey Hanson, Robert McEwen, (unknown), Marie Cumberbatch, Urszula M. Polanska, Rebecca Ellston, Oona Delpuech, Pablo Morentin Gutierrez, Lara Ward, Francisco Cruzalegui, Stephen Green	1
10	Discovery of 9-(1-anilinoethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-carboxamides as PI3Kβ/δ inhibitors for the treatment of PTEN-deficient tumours 2014 ·Bioorganic & Medicinal Chemistry Letters ·Bernard Barlaam, Sabina Cosulich, Sébastien L. Degorce, Martina Fitzek, Fabrizio Giordanetto, Stephen Green, Tord Inghardt, Laurent Hennequin, Urs J. Hancox, Christine Lambert‐van der Brempt, Rémy Morgentin, (unknown), Patrick A. Plé, (unknown), Lara Ward	17
11	Discovery of (R)-8-(1-(3,5-Difluorophenylamino)ethyl)-N,N-dimethyl-2-morpholino-4-oxo-4H-chromene-6-carboxamide (AZD8186): A Potent and Selective Inhibitor of PI3Kβ and PI3Kδ for the Treatment of PTEN-Deficient Cancers 2014 ·Journal of Medicinal Chemistry ·Bernard Barlaam, Sabina Cosulich, Sébastien L. Degorce, Martina Fitzek, Stephen Green, Urs J. Hancox, Christine Lambert‐van der Brempt, (unknown), (unknown), Rémy Morgentin, (unknown), (unknown), Patrick A. Plé, (unknown), (unknown), Mike Walker, Lara Ward, Nicolas Warin	66
12	Abstract 3264: AZD8186: a potent selective inhibitor of PI3Kβ targeting PTEN-deficient tumours dependent on dysregulated PI3Kβ signalling. 2013 ·Cancer Research ·Urs J. Hancox, Sabina Cosulich, Hannah Dry, (unknown), (unknown), Bernard Barlaam, Martina Fitzek, Lara Ward, Marie Cumberbatch, Steve Powell, Rebecca Ellston, Mandy Lawson, Stephen R. Wedge, (unknown), Stephen Green, Simon T. Barry	2
13	Biophysical Methods in Drug Discovery from Small Molecule to Pharmaceutical 2013 ·Methods in molecular biology ·Geoffrey A. Holdgate, Stefan Geschwindner, Alexander L. Breeze, Gareth M. Davies, Nicola Colclough, (unknown), Lara Ward	31
14	Discovery of novel imidazo[1,2-a]pyridines as inhibitors of the insulin-like growth factor-1 receptor tyrosine kinase 2011 ·Bioorganic & Medicinal Chemistry Letters ·Richard Ducray, Iain Simpson, Frédéric Jung, J. Willem M. Nissink, Peter W. Kenny, Martina Fitzek, Graeme E. Walker, Lara Ward, Kevin Hudson	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact